You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Claims for Patent: 7,691,384


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,691,384
Title:Method to detect IgE
Abstract: The present invention includes a method to detect IgE using a human Fc epsilon receptor (Fc.sub.68 R) to detect IgE antibodies in a biological sample from a cat, a dog, or a horse. The present invention also relates to kits to perform such methods.
Inventor(s): Frank; Glenn R. (Wellington, CO), Porter; James P. (Fort Collins, CO), Rushlow; Keith E. (Fort Collins, CO), Wassom; Donald L. (Fort Collins, CO)
Assignee: Heska Corporation (Loveland, CO)
Application Number:11/683,854
Patent Claims:1. A method to detect a plant allergy in a canid, felid or equid comprising: (a) contacting an allergen from a plant with a putative IgE containing composition from said animal, under conditions suitable for formation of an allergen:IgE complex; (b) contacting the putative allergen:IgE complex with a human Fc.epsilon.R molecule under conditions suitable for formation of an allergen:IgE:Fc.epsilon.R molecule complex, wherein either the allergen or the human Fc.epsilon.R molecule is labeled by conjugation to a detectable marker; (c) washing the allergen:IgE:Fc.epsilon.R mixture to remove non-specifically bound labeled- molecule; and (d) detecting the presence of an allergen:IgE:Fc.epsilon.R complex, if present, by detecting the presence of detectable marker, wherein the presence of an allergen:IgE:Fc.epsilon.R complex indicates the animal is allergic to said plant.

2. The method of claim 1, wherein said putative IgE containing composition comprises an animal fluid is selected from the group consisting of serum, plasma, blood, urine, tears, saliva, nasal secretions and milk.

3. The method of claim 1, wherein said allergen is selected from the group consisting of a grass allergen, a plantain allergen, a pigweed allergen, a ragweed allergen, a sage allergen, an elm allergen, a cocklebur allergen, an elder allergen, a walnut allergen, a cottonwood allergen, an ash allergen, a birch allergen, a cedar allergen, an oak allergen, and a mulberry allergen.

4. The method of claim 1, wherein said allergen is selected from the group consisting of a Johnson Grass allergen, a Kentucky Blue Grass allergen, a Meadow Fescue allergen, an Orchard Grass allergen, a Perennial Rye Grass allergen, a Redtop Grass allergen, a Timothy Grass allergen, a Bermuda Grass allergen, a Brome Grass allergen, a Curly Dock allergen, an English Plantain allergen, a Mexican Firebush allergen, a Lamb's Quarters allergen, a Rough Pigweed allergen, a Short Ragweed allergen, a Wormwood Sage allergen, an American Elm allergen, a Common Cocldebur allergen, a Box Elder allergen, a Black Walnut allergen, an Eastern Cottonwood allergen, a Green Ash allergen, a River Birch allergen, a Red Cedar allergen, a Red Oak allergen, and a Red Mulberry allergen.

5. The method of claim 1, wherein said Fc.epsilon.R molecule is encoded by a nucleic acid molecule comprising a nucleic acid sequence selected from the group consisting of SEQ ID NO:1, SEQ ID NO:4, SEQ ID NO:7, SEQ ID NO:10 and SEQ ID NO:12.

6. The method of claim 1, wherein said allergen is bound to a substrate.

7. A method to detect plant-allergen-specific IgE in a canid, felid or equid, said method comprising: (a) contacting a plant allergen with a putative IgE containing composition from said animal, under conditions suitable for formation of an allergen:IgE complex; (b) contacting the putative allergen:IgE complex with a human Fc.epsilon.R molecule under conditions suitable for formation of an allergen:IgE:Fc.epsilon.R molecule complex, wherein either the allergen or the human Fc.epsilon.R molecule is labeled by conjugation to a detectable marker; (c) washing the allergen:IgE:Fc.epsilon.R mixture to remove non-specifically bound lableled-molecule; and (d) detecting the presence of an allergen:IgE:Fc.epsilon.R complex, if present, by detecting the presence of detectable marker, wherein the presence of an allergen:IgE:Fc.epsilon.R molecule complex indicates the presence of plant-allergen-specific IgE.

8. The method of claim 7, wherein said putative IgE containing composition comprises an animal fluid is selected from the group consisting of serum, plasma, blood, urine, tears, saliva, nasal secretions and milk.

9. The method of claim 7, wherein said allergen is selected from the group consisting of a grass allergen, a plantain allergen, a pigweed allergen, a ragweed allergen, a sage allergen, an elm allergen, a cocklebur allergen, an elder allergen, a walnut allergen, a cottonwood allergen, an ash allergen, a birch allergen, a cedar allergen, an oak allergen, and a mulberry allergen.

10. The method of claim 7, wherein said allergen is selected from the group consisting of a Johnson Grass allergen, a Kentucky Blue Grass allergen, a Meadow Fescue allergen, an Orchard Grass allergen, a Perennial Rye Grass allergen, a Redtop Grass allergen, a Timothy Grass allergen, a Bermuda Grass allergen, a Brome Grass allergen, a Curly Dock allergen, an English Plantain allergen, a Mexican Firebush allergen, a Lamb's Quarters allergen, a Rough Pigweed allergen, a Short Ragweed allergen, a Wormwood Sage allergen, an American Elm allergen, a Common Cocklebur allergen, a Box Elder allergen, a Black Walnut allergen, an Eastern Cottonwood allergen, a Green Ash allergen, a River Birch allergen, a Red Cedar allergen, a Red Oak allergen, and a Red Mulberry allergen.

11. The method of claim 7, wherein said Fc.epsilon.R molecule is encoded by a nucleic acid molecule comprising a nucleic acid sequence selected from the group consisting of SEQ ID NO:1, SEQ ID NO:4, SEQ ID NO:7, SEQ ID NO:10 and SEQ ID NO:12.

12. The method of claim 7, wherein said allergen is bound to a substrate.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.